Anxin Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANXIN, and what generic and branded alternatives to ANXIN drugs are available?
ANXIN has one approved drug.
Drugs and US Patents for Anxin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anxin | SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 212970-001 | Apr 9, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.